PapersFlow Research Brief
Allergic Rhinitis and Sensitization
Research Guide
What is Allergic Rhinitis and Sensitization?
Allergic rhinitis is a symptomatic disorder of the nose induced after allergen exposure by an IgE-mediated inflammation of the membranes lining the nose, while sensitization refers to the immunological process leading to IgE production against specific allergens, often progressing to rhinitis and comorbid asthma.
Over 600 million patients worldwide suffer from allergic rhinitis, which causes major illness and disability as documented in the ARIA guidelines. The field encompasses 85,000 papers on its epidemiology, immunological mechanisms, and management, including allergen-specific immunotherapy for pollen and house dust mite allergens. Environmental factors like climate change influence pollen allergy prevalence and severity.
Topic Hierarchy
Research Sub-Topics
Allergen-Specific Immunotherapy
This sub-topic covers subcutaneous and sublingual immunotherapy protocols for desensitizing IgE responses to allergens like pollen and mites. Researchers study long-term efficacy, immune mechanisms involving Tregs, and optimal dosing schedules.
Allergic Rhinitis and Asthma Linkage
This sub-topic investigates epidemiological associations, unified airway hypothesis, and impact of rhinitis control on asthma exacerbations. Researchers analyze ARIA guidelines implementation and biomarker predictors of progression.
Pollen Allergy and Climate Change
This sub-topic examines how rising CO2, temperature, and phenological shifts increase pollen season length, allergenicity, and sensitization rates. Researchers model future burden and study cross-reactivity with new aeroallergens.
House Dust Mite Allergens
This sub-topic focuses on Der p 1/2 allergen biochemistry, exposure assessment, sensitization patterns, and environmental control measures. Researchers develop hypoallergenic vaccines and analyze mite microbiome influences.
T Regulatory Cells in Allergy
This sub-topic explores Foxp3+ Treg induction by AIT, IL-10/TGF-β networks, and genetic variants affecting suppression of Th2 responses. Researchers study peripheral tolerance markers and Treg therapy for severe rhinitis.
Why It Matters
Allergic rhinitis impairs quality of life, as measured by tools like the Dermatology Life Quality Index (DLQI), which quantifies disease impact across 120 patients with skin conditions including allergic manifestations (Finlay and Khan, 1994). It frequently coexists with asthma, prompting unified management strategies in "Allergic Rhinitis and its Impact on Asthma (ARIA) 2008" that address over 600 million affected individuals globally (Bousquet et al., 2008). Epidemiological surveys such as ISAAC reveal worldwide trends in allergic rhinoconjunctivitis symptoms among children, informing public health interventions (Asher et al., 2006). Position papers like "European Position Paper on Rhinosinusitis and Nasal Polyps 2020" provide evidence-based recommendations for diagnosis and treatment, reducing societal financial burdens from rhinosinusitis (Fokkens et al., 2020). Sublingual immunotherapy targets sensitization to improve asthma outcomes in rhinitis patients.
Reading Guide
Where to Start
"Allergic Rhinitis and its Impact on Asthma (ARIA) 2008" by Bousquet et al. (2008), as it provides a foundational global overview of allergic rhinitis definition, epidemiology affecting over 600 million patients, and its links to asthma for newcomers.
Key Papers Explained
"Allergic Rhinitis and its Impact on Asthma (ARIA) 2008" by Bousquet et al. (2008) builds on the original "Allergic Rhinitis and Its Impact on Asthma" by Bousquet et al. (2001) by updating guidelines with new evidence on IgE-mediated mechanisms and immunotherapy. ISAAC papers, including "Worldwide time trends... ISAAC Phases One and Three" by Asher et al. (2006) and "International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods" by Asher et al. (1995), supply epidemiological data that underpin ARIA classifications. "European Position Paper on Rhinosinusitis and Nasal Polyps 2020" by Fokkens et al. (2020) extends these to rhinosinusitis management, integrating quality-of-life measures like DLQI from Finlay and Khan (1994).
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Recent guidelines emphasize immunotherapy for pollen and house dust mite sensitization amid climate change influences, as synthesized in EPOS 2020 and ARIA updates. Frontiers include T regulatory cell roles in immunological mechanisms and epidemiological tracking of asthma-rhinitis comorbidity via ISAAC methodologies. No preprints available in the last 6 months indicate reliance on established position papers for current practice.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | European Position Paper on Rhinosinusitis and Nasal Polyps 2020 | 2020 | Rhinology Journal | 5.4K | ✓ |
| 2 | Dermatology Life Quality Index (DLQI)-a simple practical measu... | 1994 | Clinical and Experimen... | 5.3K | ✕ |
| 3 | Allergic Rhinitis and its Impact on Asthma (ARIA) 2008* | 2008 | Allergy | 4.6K | ✓ |
| 4 | Technical Details of Intraoperative Lymphatic Mapping for Earl... | 1992 | Archives of Surgery | 4.4K | ✕ |
| 5 | Worldwide time trends in the prevalence of symptoms of asthma,... | 2006 | The Lancet | 4.2K | ✕ |
| 6 | International Study of Asthma and Allergies in Childhood (ISAA... | 1995 | European Respiratory J... | 3.7K | ✓ |
| 7 | Allergic Rhinitis and Its Impact on Asthma | 2001 | Journal of Allergy and... | 3.5K | ✕ |
| 8 | Worldwide variation in prevalence of symptoms of asthma, aller... | 1998 | The Lancet | 3.4K | ✕ |
| 9 | The Definition and Classification of Dry Eye Disease: Report o... | 2007 | The Ocular Surface | 3.2K | ✕ |
| 10 | The validity and practicality of sun-reactive skin types I thr... | 1988 | Archives of Dermatology | 3.2K | ✕ |
Frequently Asked Questions
What is allergic rhinitis?
Allergic rhinitis is a symptomatic disorder of the nose induced after allergen exposure by an IgE-mediated inflammation of the membranes lining the nose. It affects over 600 million patients worldwide, causing major illness and disability. Management strategies include allergen-specific immunotherapy as outlined in ARIA guidelines.
How does allergic rhinitis impact asthma?
Allergic rhinitis often coexists with asthma, influencing its control through shared IgE-mediated mechanisms and sensitization pathways. "Allergic Rhinitis and its Impact on Asthma (ARIA) 2008" recommends integrated treatment approaches for both conditions. This comorbidity affects quality of life and requires epidemiological monitoring via studies like ISAAC.
What are key methods for managing allergic rhinitis?
"European Position Paper on Rhinosinusitis and Nasal Polyps 2020" offers evidence-based recommendations on diagnosis and treatment of rhinosinusitis linked to allergic rhinitis. Allergen-specific immunotherapy, including sublingual forms, targets sensitization to pollen and house dust mite allergens. These strategies mitigate progression to asthma.
What do major papers say about allergic rhinitis epidemiology?
"Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three" documents global prevalence variations (Asher et al., 2006). "Allergic Rhinitis and Its Impact on Asthma" classifies its global burden (Bousquet et al., 2001). ISAAC methods standardize cross-country surveys for accurate trends.
How is quality of life assessed in allergic rhinitis?
The Dermatology Life Quality Index (DLQI) is a simple questionnaire for routine clinical use, validated across 120 patients with skin diseases including allergic conditions (Finlay and Khan, 1994). It measures disease and treatment impact on daily life. ARIA guidelines incorporate such tools for comprehensive patient evaluation.
What is the current state of allergic rhinitis research?
Research totals 85,000 works focusing on immunotherapy, T regulatory cells, and climate change effects on pollen allergy. Key guidelines like ARIA 2008 and EPOS 2020 guide clinical practice. No recent preprints reported in the last 6 months.
Open Research Questions
- ? How do climate change and environmental factors alter pollen sensitization patterns and allergic rhinitis severity?
- ? What immunological mechanisms involving T regulatory cells best predict progression from sensitization to persistent allergic rhinitis and asthma?
- ? Which patient subgroups derive most benefit from sublingual versus other forms of allergen-specific immunotherapy for house dust mite allergens?
- ? How can ISAAC-like surveys be refined to track long-term global trends in allergic rhinoconjunctivitis amid rising comorbidities?
- ? What biomarkers accurately differentiate allergic rhinitis sensitization from rhinosinusitis and nasal polyps?
Recent Trends
The field holds steady at 85,000 papers with no 5-year growth data reported.
Influential updates include "European Position Paper on Rhinosinusitis and Nasal Polyps 2020" by Fokkens et al., cited 5368 times, refining diagnosis amid rising rhinosinusitis burdens.
ARIA frameworks from Bousquet et al. (2008, 4631 citations) continue to dominate management of sensitization and asthma links, with no new preprints or news in the last 12 months.
Research Allergic Rhinitis and Sensitization with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Allergic Rhinitis and Sensitization with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers